This inventor holds 3 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 1 EPO patent. Top assignees: Ignyta, Inc., Nerviano Medical Sciences S.r.l.. Active years: 2019-2020.
Company Filing History:
3 out of 25 
3 out of 139 
Years Active: 2019-2020
Title: Innovations by Inventor Elena Ardini
Introduction
Elena Ardini is a notable inventor based in Sesto San Giovanni, Italy. She has made significant contributions to the field of cancer research, particularly in the development of therapeutic compounds. With a total of three patents to her name, her work focuses on addressing diseases associated with deregulated protein kinase activity.
Latest Patents
Elena Ardini's latest patents include groundbreaking innovations such as molecules for administration to ROS1 mutant cancer cells. These patents detail substituted indazole derivatives and their pharmaceutically acceptable salts, which may be useful in treating various cancers. Additionally, she has developed methods for treating neuroblastoma, which also involves the administration of these substituted indazole derivatives.
Career Highlights
Throughout her career, Elena has worked with prominent companies in the pharmaceutical industry, including Ignyta, Inc. and Nerviano Medical Sciences S.r.l. Her experience in these organizations has allowed her to contribute to significant advancements in cancer treatment.
Collaborations
Elena has collaborated with esteemed colleagues such as Jonathan Lim and Maria Menichincheri. These partnerships have further enhanced her research and development efforts in the field of oncology.
Conclusion
Elena Ardini's innovative work and dedication to cancer research have positioned her as a key figure in the development of new therapeutic methods. Her contributions continue to pave the way for advancements in the treatment of complex diseases.